A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT02835729 · COMPLETED
Trial details
- NCT number
- NCT02835729
- Sponsor
- NewLink Genetics Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2019-10-25
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.